Rockefeller Capital Management L.P. Eli Lilly & CO Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

A detailed history of Rockefeller Capital Management L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 479,020 shares of LLY stock, worth $381 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

479,020

Previous 526,479 9.01%

Holding current value

$381 Million

Previous $477 Million 10.97%

% of portfolio

1.17%

Previous 1.37%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $36.6 Million - $45.6 Million	-47,459 Reduced 9.01%	479,020 $424 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $2.84 Million - $3.56 Million	-3,920 Reduced 0.74%	526,479 $477 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $8.31 Million - $11.1 Million	14,038 Added 2.72%	530,399 $413 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $3.55 Million - $4.18 Million	6,758 Added 1.33%	516,361 $301 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $13.9 Million - $19.2 Million	-32,065 Reduced 5.92%	509,603 $274 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $16.4 Million - $22 Million	-46,871 Reduced 7.96%	541,668 $254 Million
Q1 2023 May 17, 2023	BUY	$310.63 - $364.82 $18.2 Million - $21.3 Million	58,445 Added 11.03%	588,539 $202 Million
Q4 2022 Mar 06, 2023	SELL	$321.55 - $374.67 $69.2 Million - $80.7 Million	-215,319 Reduced 28.89%	530,094 $194 Million
Q3 2022 Nov 02, 2022	SELL	$296.48 - $337.87 $5.46 Million - $6.22 Million	-18,409 Reduced 2.41%	745,413 $241 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $6.15 Million - $7.22 Million	22,068 Added 2.98%	763,822 $248 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $5.06 Million - $6.28 Million	-21,547 Reduced 2.82%	741,754 $212 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $21.1 Million - $26.2 Million	93,969 Added 14.04%	763,301 $211 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $3.01 Million - $3.71 Million	13,597 Added 2.07%	669,332 $155 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $2.77 Million - $3.58 Million	15,320 Added 2.39%	655,735 $151 Million
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $89 Million - $115 Million	541,706 Added 548.79%	640,415 $120 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $3.87 Million - $5.13 Million	29,690 Added 43.02%	98,709 $16.7 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $1.83 Million - $2.12 Million	12,548 Added 22.22%	69,019 $10.2 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $12,550 - $15,104	92 Added 0.16%	56,471 $9.27 Million
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $401,436 - $496,864	3,372 Added 6.36%	56,379 $7.82 Million
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $1.13 Million - $1.4 Million	10,536 Added 24.81%	53,007 $6.97 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $3.02 Million - $3.29 Million	28,311 Added 199.94%	42,471 $4.75 Million
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $312,649 - $364,941	-2,822 Reduced 16.62%	14,160 $1.57 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $564,007 - $663,878	-5,067 Reduced 22.98%	16,982 $2.2 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $1.81 Million - $2.03 Million	17,090 Added 344.63%	22,049 $2.55 Million
Q2 2018 Jul 31, 2018	BUY	$75.7 - $86.88 $14,458 - $16,594	191 Added 4.01%	4,959 $423,000
Q1 2018 May 09, 2018	BUY	$74.21 - $87.6 $353,833 - $417,676	4,768 New	4,768 $369,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Eli Lilly & CO Transaction History